Member Info for Dosanddonts

Anybody have any idea who the investors are? as it seems LB have also had enough, as not throwing anymore cash at it! Really didn’t expect a fund raise, even the directors at 1p are unwilling to invest, new CEO AD £50k is not bad but £5k by AH & KJ, when the latter two have been taking £250k salaries per year is a joke.

Well one thing with LB now somewhat in charge shareholder value will be top of the agenda, as long as their not trying to do us other shareholders over! We will see but Eroxon intense news on it’s own will have zero effect on the SP as pressing matter here is funding and revenue increase! Once all Ducks are aligned then hopefully we will see a string of positive news, let’s hope!! But imo this will not happen until 2026 Q1.

Whealerdealer you have done well , wish I’d sold and bought back in but had confidence in a company that short changed me imo! But issue is the shocking state of the AIM market to be honest! This will rise eventually as the fundermendals haven't changed they still have great potential more so now then ever yet SP don’t reflect it! Slow sales on a new product is not unexpected yet has infiltrated the market remarkably well selling in all markets & across 25 countries nothing to be sniffed at in the short timescale they have achieved this! AIM is useless at valuing companies & that is the issue! Just over values and under values imo needs to sort itself out as currently not working & will shut down if it don’t fix itself very soon. Wudnt be surprised if FuM exits the market very soon!

If you look at USA reviews across the board they seem to be massively improving Target 4star,,granted a lot are promotional targeted but a move in the right direction imo! Good luck to all even if your a bottom feeders AIM is a tough market!

Mxd- seems you just hover around shares on the decline like a bad smell, get in touch with the Lordtossa you two would get along like fw in a pod! Another sado

Nothing worse than when bottom feeders move in with their non logical ramping for short term gains! A re rate based on what you fw! But can’t blame them as current price is a joke considering!

Walmart has been out of stock online in the USA for a week but they are now back in stock, hopefully stock levels are being depleted everywhere & will start being replenished.

People keep saying FUM is a failed company & I totally agree, the R&D was to transfer drugs through the skin using their topical treatment Dermasys! It failed and for 15years these idiots persisted, JB & his cronies that is! So they can’t say they are experts in R&D, they basically hit it lucky & have now managed to create x3 products from the Dermsys formulation failure (got to laugh). That’s why JB should have gone years ago & a new team put in place. Sick of hearing about their great R&D team??? FUM imo should have sold Eroxon as an IP model & not Direct sales model, & not spent all its cash on setting up CMO’s. once the current products including WSD4000 are complete, FUM will be defunct & that’s the reason they set themselves up as DSM so they had future jobs! They only need a skeleton crew to deliver Eroxon Intense & WSD4000, and the new CEO clearly knows that! If these products gain traction & I'm still hoping that will happen just not what was originally forecast then they will sell the products or a TO. ( may come sooner than we think) Either way these products serve an untapped market so sales are additional to existing ED treatment sales. So this will sit well with other ED manufacturers who maybe interested if contracts expire. Just a thought!

Think we would be giving him to much credit there,! but he does have a deep seated hate that he needs professional therapy for, maybe Eroxon might help take your mind off it? Just a thought rub it on your head!

Lordtossa-sales are not as expected but it is still selling with decent sales for a new product! I keep on asking you why do retailers still stock it if it’s not selling & you can’t answer it. Because none of your rants are based on any fact just your deep hate of FUM for some reason which again you refuse to disclose.

Well it’s got the best chance of success as its in all the large retailers across 25 countries, all testing has confirmed it does work by FUM & partners independent testing, so we will see in the years ahead! This could rise as fast as it fell especially on the AIM market. FUM needs a ceo & team that are fluent in social media marketing to drive sales on the cheap! Deliver fast returns for LB & us shareholders.

Let’s take out the milestone payments and we see a different picture emerging, yes lower sales but not the horrendous dip that they like to advertise. Let’s also remember that first profits weren’t expected until 2025 of £1m if I remember correctly! Then they got carried away & made a dogs dinner of it!

Eroxon sales:

2023 - £3m (instocking for UK & Belgium) £30m retail

2024 - £7m (instocking for EU & USA & RoW) £70m retail

2025 - £1.4m sales £14m retail (restocking levels will have been reduced so sales probably higher)

2026 - ??

Share price is on its knees but I would still like someone to tell me if sales are so bad why do boots/ Superdrug & all the rest still give it shelf space or even sell it at all?? It may not currently be the super selling product, but clearly retailers are making money from it & as they have already said it’s not just shifting sales from one product to another, it’s new sales that don’t exist without it. & Viagra was the only ED med available when released that’s not the case today so it will take some selling when ED pulls are so cheap.

PS-Lordtossa if this is going bust by Xmas you need to get a hobby fast otherwise the poor wife is going to be demented!!

One hell of a sham retailers bought £80m worth of the product last year, and around £15m this year.

You are denying the data for f sake, the FDA approved it as did everyone else! But no we must take your word for it based on not conducting a trial! Guessing the 5G towers caused covid as nobody proved they didn’t! Doh!

To be honest nobody gives a monkey if it’s a placebo or not, as sales are what count & currently sales are terrible! At least we can agree on something that the product is not achieving the sales needed. Question is whether this can change or not? Being a placebo or not, will not change the sales!

Lordtossa wrong again you have manipulated the term placebo for your own lies!

Characteristics of a placebo

No active ingredients: Placebos contain no pharmacologically active substances. They are made to look identical to the real treatment, so participants in a study cannot tell the difference.

Therapeutic context: A placebo's effectiveness is not due to its inert components, but to the context surrounding its use, such as the patient's belief and expectation of a beneficial outcome. This phenomenon is known as the "placebo effect".

Nicname- you are as you know the facts and try to manipulate them , here is the definition:

“dishonesty, fraudulent conduct, false statements made knowing them to be untrue, by which the liar intends to deceive a party receiving the statements and expects the party to believe and rely on them.”

I personally don’t think it’s efficiency more taking any market from current meds, as I say paracetamol vs morphine we h were n your already taking morphine!!

Elephant in the room here is still UK market, it been selling in UK for 1.5 years longer than US, had good penetration & NHS took it onboard. Where is the data from this? 20% market share in first year which we know has declined why? People trying Eroxon alongside PDE5 inhibitors them reverting back to PDE5 inhibitors my guess? Point is this was the 1st market for Eroxon & gained good traction with NHS involved, with Eroxon being recommended as a first line treatment due to no side effects! So what is happening in the UK it’s pretty much a blue print for everyone else!!! IMO. It’s 1.5 years ahead so what is the traction with new ED patients as to me this is the market, nobody wants to take a pill it’s the last resort!